H.R. 1922

119th CONGRESS 1st Session

To amend title XVIII of the Social Security Act to exempt certain drugs from the part D manufacturer discount program under the Medicare program.

IN THE HOUSE OF REPRESENTATIVES · March 6, 2025 · Sponsor: Mr. Garbarino

Table of contents

• H.R. 1922
  • SEC. 1. Short title
  • SEC. 2. Exempting certain drugs from the part D manufacturer discount program under the Medicare program

SEC. 1. Short title

• This Act may be cited as the Ensuring Access to Essential Drugs Act.

SEC. 2. Exempting certain drugs from the part D manufacturer discount program under the Medicare program

• Section 1860D–14C(g)(2) of the Social Security Act (42 U.S.C. 1395w–114c(g)(2)) is amended—
  • in subparagraph (A), by striking and at the end;
  • in subparagraph (B), by striking the period and inserting ; and; and
    • does not include an orally administered drug—
      • (i) for which a new drug application was approved under section 505 of the Federal Food, Drug, and Cosmetic Act; and
      • (ii) that has been granted a narrow exception permitting reclassification as a noninnovator multiple source drug under the Medicaid drug rebate program by the Centers for Medicare & Medicaid Services.
  • by adding at the end the following new subparagraph: